Journals / MN Oftalmoloji / 2017 / Cilt: 24 - Sayı: 1

Cultured Limbal Stem Cell Transplantation in Limbal Stem Cell Deficiency

Limbal Kök Hücre Yetmezliğinde Kültüre Edilmiş Limbal Kök Hücre Nakli

Pages
106–114
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

If limbal stem cells are notobtained from the other eye, other stem cell sources such as oral mucosa can be used.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Autologous (from the other eye) or allogenic (living related or cadaver) limbal stem cell transplantation is the only treatmentmodality of limbal stem cell deficiency, except palliative medical therapy.
📊
Key Findings & Data:The success rates of the limbal stem cell transplantations are reported to be around 70%.
💡
Conclusion & Impact:If limbal stem cells are notobtained from the other eye, other stem cell sources such as oral mucosa can be used.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Autologous (from the other eye) or allogenic (living related or cadaver) limbal stem cell transplantation is the only treatmentmodality of limbal stem cell deficiency, except palliative medical therapy. Long term immunosuppressive treatment due tohigh risk of rejection is the most important disadvantage of the allograft limbal stem cell transplantation. Despite being expensive, cultured limbal stem cell transplantation is the preferred method due to lower risk and it can be repeated when necessary. The success rates of the limbal stem cell transplantations are reported to be around 70%. If limbal stem cells are notobtained from the other eye, other stem cell sources such as oral mucosa can be used.

Özet

Limbal kök hücre yetmezliğinin palyatif tedavisi dışında tek tedavi yöntemi otolog (diğer gözden) veya allograft (akrabalarveya kadavra) limbal kök hücre naklidir. Allograft limbal kök hücre naklinin en önemli dezavantajı, otolog nakillerde gelişmeyen rejeksiyon olasılığı nedeniyle uzun süre immünosüpresif kullanılmasıdır. Kültüre edilmiş limbal kök hücre nakli, hastanın diğer gözünden alınan biyopsinin çok küçük olması, daha az riskli olması ve tekrarlanabilmesi nedeniyle en çok tercihedilen ancak pahalı bir yöntemdir. Limbal kök hücre nakillerinin başarı oranları %70 civarında olduğu bildirilmiştir. Kültüriçin diğer gözden kök hücre elde edilemediğinde, ağız mukozası gibi limbus dışı başka kök hücre kaynakları da kullanılabilir.

🔖

Cite This Article

DURAK, İ. (2017). Cultured Limbal Stem Cell Transplantation in Limbal Stem Cell Deficiency. MN Oftalmoloji, Cilt: 24 - Sayı: 1, 106–114. https://ajindex.com/articles/295454

References (18)

  1. Grueterich M. Espana EM. Tseng SC. Ex Vivo Ex pan - sion of Limbal Epithelial Stem Cells: Amniotic Memb - rane Serving as a Stem Cell Niche. Surv Opht hal mol 2003
  2. 46 2. Wolosin JM. Xiong X. Schutte M. Stegman Z. Tieng A. Stem cells and differentiation stages in the limbocorneal epithelium. Prog Retin Eye Res 2000
  3. Romano AC. Espana EM, Budak MT. Wolosin JM. Tseng SC. Different cell sizes in human limbal and central corneal basal epithelia measured by confocal microscopy and flow cytometry. Invest Ophthalmol Vis Sci 2003
  4. 9 4. Kinoshita S. Adachi W. Sotozono C. et al. Charac te - ris tics of the human ocular surface epithelium.Prog Retin Eye Res 2001
  5. Goldberg MF. Bron AJ. Limbal palisades of Vogt. Trans Am Ophthalmol Soc 1982
  6. Dua HS. Shanmuganathan VA. Powell-Richards AO. Tighe PJ. Joseph A. Limbal epithelial crypts:a novel anatomical structure and a putative limbal stem cell niche. Br J Ophthalmol 2005
  7. Shortt AJ. Secker GA. Notara MD. Limb GA. Khaw PT. Tuft SJ. Daniels JT. Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results. Surv Ophthalmol 2007
  8. 52(5):483-502 8. Singh V. Shukla S. Ramachandran C. et al. Science and Art of Cell-Based Ocular Surface Regeneration. Int Rev Cell Mol Biol 2015
  9. 106 9. Li DQ. Wang Z. Yoon KC. Bian F. Characterization, isolation, expansion and clinical therapy of human corneal epithelial stem/progenitor cells. J Stem Cells 2014
  10. 9(2):79-91 10. Dua HS, Miri A, Said DG Contemporary limbal stem cell transplantation - a review. Clin Exp Ophthalmol 2010
  11. 38(2):104-1 11. Holland EJ. Management of limbal stem cell deficiency: a historical perspective, past, present, and future. Cornea. 2015
  12. 34(suppl 10):S9-S15 12. Thoft RA. Conjunctival transplantation. Arch Ophthal - mol 1977
  13. 95(8):1425-7 13. Thoft RA. Keratoepithelioplasty. Am J Ophthalmol 1984
  14. Kenyon KR. Tseng SCG. Limbal autograft transplantation for ocular surface disorders. Ophthalmology 1989
  15. 23 15. Tsai RJF. Tseng SCG. Human allograft limbal transplantation for corneal surface reconstruction. Cornea 1994
  16. Kwitko S. Raminho D. Barcaro S. et al. Allograft conjunctival transplantation for bilateral ocular surface disorders. Ophthalmology 1995
  17. Kenyon KR. Rapoza PA. Limbal allograft transplantation for ocular surface disorders. Ophthalmology 1995
  18. 102(suppl):101-2. 18. Daya SM. Chan CC. Holland EJ. Cor